3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
3
Gynecologic
1
Gastrointestinal
1
CNS
1
Conditions
Glioblastoma
3
Glioma
2
Uveal Melanoma
1
Recurrence
1
Carcinoma, Hepatocellular
1
Carcinoma
1
Interventions
pembrolizumab
2
Radiosurgery
2
Cyclophosphamide
2
pentetreotide
1
fludarabine phosphate
1
entinostat
1
Thrombopoietin
1
Specimen Handling
1
Nivolumab
1
Magnetic Resonance Spectroscopy
1
LY2940680
1
Ipilimumab
1
Interleukin-13
1
Immunologic Techniques
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Fluorodeoxyglucose F18
1
Filgrastim
1
Etoposide
1
Cryosurgery
1
Carboplatin
1
CTLA-4 Antigen
1
Biopsy
1
Amplified Fragment Length Polymorphism Analysis
1
ADI PEG20
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
ADI PEG20
×
CNS
×
Clear all
NCT02029690
2020-09-25
TRAP
Polaris Group
Phase 1
Terminated
85 enrolled